FATE THERAPEUTICS INC's ticker is and the CUSIP is 31189P952. A total of 3 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $33,764 | +165.4% | 4,600 | -23.3% | 0.00% | – |
Q3 2023 | $12,720 | -13.8% | 6,000 | +93.5% | 0.00% | – |
Q2 2023 | $14,756 | -13.7% | 3,100 | +3.3% | 0.00% | – |
Q1 2023 | $17,100 | -47.0% | 3,000 | -6.2% | 0.00% | – |
Q4 2022 | $32,288 | -84.8% | 3,200 | -66.3% | 0.00% | – |
Q3 2022 | $213,000 | -36.8% | 9,500 | -30.1% | 0.00% | -100.0% |
Q2 2022 | $337,000 | -45.0% | 13,600 | -13.9% | 0.00% | 0.0% |
Q1 2022 | $613,000 | -66.3% | 15,800 | -49.2% | 0.00% | 0.0% |
Q4 2021 | $1,820,000 | -10.2% | 31,100 | -9.1% | 0.00% | -50.0% |
Q3 2021 | $2,027,000 | +309.5% | 34,200 | +500.0% | 0.00% | +100.0% |
Q2 2021 | $495,000 | +234.5% | 5,700 | +216.7% | 0.00% | – |
Q1 2021 | $148,000 | +80.5% | 1,800 | +100.0% | 0.00% | – |
Q4 2020 | $82,000 | -93.1% | 900 | -97.4% | 0.00% | -100.0% |
Q2 2020 | $1,184,000 | +145.6% | 34,500 | +59.0% | 0.01% | +25.0% |
Q1 2020 | $482,000 | +412.8% | 21,700 | +352.1% | 0.00% | +300.0% |
Q4 2019 | $94,000 | +100.0% | 4,800 | +60.0% | 0.00% | – |
Q3 2019 | $47,000 | +135.0% | 3,000 | +200.0% | 0.00% | – |
Q2 2019 | $20,000 | -92.2% | 1,000 | -93.2% | 0.00% | -100.0% |
Q1 2019 | $257,000 | -23.5% | 14,600 | -44.3% | 0.00% | 0.0% |
Q4 2018 | $336,000 | +44.2% | 26,200 | +83.2% | 0.00% | +50.0% |
Q3 2018 | $233,000 | -54.3% | 14,300 | -68.2% | 0.00% | -50.0% |
Q2 2018 | $510,000 | +129.7% | 45,000 | +98.2% | 0.00% | +100.0% |
Q1 2018 | $222,000 | – | 22,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 21,700 | $482,000 | 0.00% |
SIMPLEX TRADING, LLC | 546 | $1,212,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |